According to Eurofins Scientific's latest financial reports the company has NZ$1.11 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | NZ$1.13 B | -46.94% |
2023-12-31 | NZ$2.13 B | 159.66% |
2022-12-31 | NZ$0.82 B | -3.78% |
2021-12-31 | NZ$0.85 B | -45.07% |
2020-12-31 | NZ$1.55 B | 214.84% |
2019-12-31 | NZ$0.49 B | -42.78% |
2018-12-31 | NZ$0.86 B | -37.71% |
2017-12-31 | NZ$1.38 B | 10.48% |
2016-12-31 | NZ$1.25 B | -1.08% |
2015-12-31 | NZ$1.26 B | 277.13% |
2014-12-31 | NZ$0.33 B | -32.69% |
2013-12-31 | NZ$0.49 B | 131.36% |
2012-12-31 | NZ$0.21 B | -27.71% |
2011-12-31 | NZ$0.29 B | 61.14% |
2010-12-31 | NZ$0.18 B | 72.85% |
2009-12-31 | NZ$0.10 B | -66.19% |
2008-12-31 | NZ$0.31 B | 156.91% |
2007-12-31 | NZ$0.12 B | -17.96% |
2006-12-31 | NZ$0.15 B | 110.55% |
2005-12-31 | NZ$71.47 M | 3.87% |
2004-12-31 | NZ$68.8 M |